For example, a nuclear localization of Slug wasestablished only in 3.7% of tumor samples; i.e., the clinical significance ofthis indicator is very limited [92].Based on other data, 25% of uterine corpus cancer cases had high Slugexpression; this indicator is associated with recurrence-free survival;therefore, it may be considered a poor prognosis factor [93]. This evidence concerns the gene SNAI2 and uterine corpus cancer.